🚀 VC round data is live in beta, check it out!
Ecomiam Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ecomiam and similar public comparables like New Nordic Healthbrands, Willamette Valley, Laboratorio Farmaceutico, Biogena and more.
Ecomiam Overview
About Ecomiam
Ecomiam SA is engaged in distribution of frozen products. The company's products include Aperitifs; Meats; Fish & Seafood; Vegetables & Potato; Culinary aids; On the go; Breads & Pastries; Desserts; and Organic.
Founded
2009
HQ
Employees
N/A
Website
Financials (LTM)
EV
$14M
Ecomiam Financials
Ecomiam reported last 12-month revenue of $49M and negative EBITDA of ($2M).
In the same LTM period, Ecomiam generated ($2M) in EBITDA losses and had net loss of ($4M).
Revenue (LTM)
Ecomiam P&L
In the most recent fiscal year, Ecomiam reported revenue of $46M and EBITDA of ($3M).
Ecomiam expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $49M | XXX | $46M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $18M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 39% | XXX | XXX | XXX |
| EBITDA | ($2M) | XXX | ($3M) | XXX | XXX | XXX |
| EBITDA Margin | (5%) | XXX | (6%) | XXX | XXX | XXX |
| EBIT Margin | (7%) | XXX | (7%) | XXX | XXX | XXX |
| Net Profit | ($4M) | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | (8%) | XXX | (9%) | XXX | XXX | XXX |
| Net Debt | — | — | $755K | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Ecomiam Stock Performance
Ecomiam has current market cap of $13M, and enterprise value of $14M.
Market Cap Evolution
Ecomiam's stock price is $2.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14M | $13M | 0.0% | XXX | XXX | XXX | $-0.75 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialEcomiam Valuation Multiples
Ecomiam trades at 0.3x EV/Revenue multiple, and (5.6x) EV/EBITDA.
EV / Revenue (LTM)
Ecomiam Financial Valuation Multiples
As of March 16, 2026, Ecomiam has market cap of $13M and EV of $14M.
Equity research analysts estimate Ecomiam's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ecomiam has a P/E ratio of (3.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV (current) | $14M | XXX | $14M | XXX | XXX | XXX |
| EV/Revenue | 0.3x | XXX | 0.3x | XXX | XXX | XXX |
| EV/EBITDA | (5.6x) | XXX | (4.7x) | XXX | XXX | XXX |
| EV/EBIT | (4.4x) | XXX | (4.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 0.8x | XXX | XXX | XXX |
| P/E | (3.3x) | XXX | (3.1x) | XXX | XXX | XXX |
| EV/FCF | (3.8x) | XXX | (4.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ecomiam Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Ecomiam Margins & Growth Rates
Ecomiam's revenue in the last 12 month grew by 25%.
Ecomiam's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ecomiam's rule of X is 57% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Ecomiam Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 25% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | (5%) | XXX | (6%) | XXX | XXX | XXX |
| EBITDA Growth | (100%) | XXX | (33%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 57% | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 26% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 46% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Ecomiam Public Comps
See public comps and valuation multiples for other Food & Beverages and Wholesale Distribution comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| New Nordic Healthbrands | XXX | XXX | XXX | XXX | XXX | XXX |
| Willamette Valley | XXX | XXX | XXX | XXX | XXX | XXX |
| Laboratorio Farmaceutico | XXX | XXX | XXX | XXX | XXX | XXX |
| Biogena | XXX | XXX | XXX | XXX | XXX | XXX |
| Amatheon Agri Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ecomiam M&A Activity
Ecomiam acquired XXX companies to date.
Last acquisition by Ecomiam was on XXXXXXXX, XXXXX. Ecomiam acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Ecomiam
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialEcomiam Investment Activity
Ecomiam invested in XXX companies to date.
Ecomiam made its latest investment on XXXXXXXX, XXXXX. Ecomiam invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Ecomiam
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ecomiam
| When was Ecomiam founded? | Ecomiam was founded in 2009. |
| Where is Ecomiam headquartered? | Ecomiam is headquartered in France. |
| Is Ecomiam publicly listed? | Yes, Ecomiam is a public company listed on Euronext Paris. |
| What is the stock symbol of Ecomiam? | Ecomiam trades under ALECO ticker. |
| When did Ecomiam go public? | Ecomiam went public in 2020. |
| Who are competitors of Ecomiam? | Ecomiam main competitors are New Nordic Healthbrands, Willamette Valley, Laboratorio Farmaceutico, Biogena. |
| What is the current market cap of Ecomiam? | Ecomiam's current market cap is $13M. |
| What is the current revenue of Ecomiam? | Ecomiam's last 12 months revenue is $49M. |
| What is the current revenue growth of Ecomiam? | Ecomiam revenue growth (NTM/LTM) is 25%. |
| What is the current EV/Revenue multiple of Ecomiam? | Current revenue multiple of Ecomiam is 0.3x. |
| Is Ecomiam profitable? | No, Ecomiam is not profitable. |
| What is the current EBITDA of Ecomiam? | Ecomiam has negative EBITDA and is not profitable. |
| What is Ecomiam's EBITDA margin? | Ecomiam's last 12 months EBITDA margin is (5%). |
| What is the current EV/EBITDA multiple of Ecomiam? | Current EBITDA multiple of Ecomiam is (5.6x). |
| What is the current FCF of Ecomiam? | Ecomiam's last 12 months FCF is ($4M). |
| What is Ecomiam's FCF margin? | Ecomiam's last 12 months FCF margin is (7%). |
| What is the current EV/FCF multiple of Ecomiam? | Current FCF multiple of Ecomiam is (3.8x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.